Venous Thromboembolism (VTE) Clinical Trials

12 recruiting

Venous Thromboembolism (VTE) Trials at a Glance

13 actively recruiting trials for venous thromboembolism (vte) are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Houston, San Antonio, and Baltimore. Lead sponsors running venous thromboembolism (vte) studies include Regeneron Pharmaceuticals, Johannes Gutenberg University Mainz, and Insel Gruppe AG, University Hospital Bern.

Browse venous thromboembolism (vte) trials by phase

Treatments under study

About Venous Thromboembolism (VTE) Clinical Trials

Looking for clinical trials for Venous Thromboembolism (VTE)? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Venous Thromboembolism (VTE) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Venous Thromboembolism (VTE) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 3

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled14 locationsNCT07213778
Recruiting
Phase 3

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled41 locationsNCT07015905
Recruiting
Not Applicable

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

Quality of Life (QOL)Exercise TherapyAnxiety Depression+7 more
Insel Gruppe AG, University Hospital Bern160 enrolled5 locationsNCT07143539
Recruiting

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Lung Cancer (Diagnosis)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
The First Hospital of Jilin University900 enrolled1 locationNCT07439991
Recruiting
Phase 3

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

Venous Thromboembolism (VTE)Postpartum
Marc Blondon9,200 enrolled1 locationNCT07140211
Recruiting

External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients

Venous Thromboembolism (VTE)Occult Cancer
Infanta Leonor University Hospital500 enrolled12 locationsNCT07310693
Recruiting

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

NSCLC (Advanced Non-small Cell Lung Cancer)Venous Thromboembolism (VTE)
University Of Perugia500 enrolled1 locationNCT07288632
Recruiting

Heat Shock Protein 47 in Thrombosis

Venous Thromboembolism (VTE)Stroke (in Patients With Atrial Fibrillation)Acute Myocardial Infarction With ST Segment Elevation
University of Aarhus340 enrolled2 locationsNCT06731673
Recruiting
Phase 4

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

Venous Thromboembolism (VTE)
University Hospital, Brest2,400 enrolled18 locationsNCT06845423
Recruiting
Phase 4

Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis

Intensive Care MedicineVenous ThromboembolismVenous Thromboembolism (VTE)
Science Valley Research Institute50 enrolled1 locationNCT06958588
Recruiting

VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE

Pulmonary Embolism (PE)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
Johannes Gutenberg University Mainz2,000 enrolled1 locationNCT02156401
Recruiting

The Butterfly study. A trial assessing acceptability and safety of using a subcutanous catheter to administer enoxaparin (Clexane) in patients requiring long-term therapy for treatment or prevention of blood clots.

Pulmonary Embolism (PE)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
Monash Health40 enrolled2 locationsACTRN12622001059752
Recruiting
Phase 4

Thrombophilia in Pregnancy Prophylaxis Study: a multicentre, multinational, randomised controlled trial of prophylactic low molecular weight heparin in high-risk pregnant thrombophilic women.

Venous thromboembolism (VTE) and placenta mediated pregnancy complications in thrombophilic women.
The Ottawa Health Research Institute385 enrolled32 locationsACTRN12608000446369